auto
Find a product
Back to results

Human IL-6 Quantikine HS ELISA Kit R&D Systems #HS600B

Human IL-6 Quantikine HS ELISA Kit

  • Company: R&D Systems
  • Product code: HS600B
  • Review rating:4.00 (1 review)

Product Details

1DB_ID: 1DB-001-0001213491
Company: R&D Systems
Company product code: HS600B
Product name: Human IL-6 Quantikine HS ELISA Kit
Product type: Kit, Antibody
Size/Price: 1 Kit/
Target: IL6
Tested applications: ELISA
Species: Human
Description: Interleukin 6 (IL-6) is a pleiotropic a-helical 22-28 kDa phosphorylated and variably glycosylated (1-5) cytokine. Mature human IL-6 is 183 amino acids (aa) in length and shares 41% aa sequence identity with mouse and rat IL-6 (6). Alternate splicing generates several isoforms with internal deletions, some of which exhibit antagonistic properties (7-10). Cells known to express IL-6 include CD8+ T cells, fibroblasts, synoviocytes, adipocytes, osteoblasts, megakaryocytes, endothelial cells (under the influence of endothelins), sympathetic neurons, cerebral cortex neurons, adrenal medulla chromaffin cells, retinal pigment cells, mast cells, keratinocytes, Langerhans cells, fetal and adult astrocytes, neutrophils, monocytes, eosinophils, colonic epithelial cells, B1 B cells, and pancreatic islet beta cells (2, 7, 10-33). IL-6 production is generally correlated with cell activation and is normally kept in control by glucocorticoids, catecholamines and secondary sex steroids (2). Normal human circulating IL-6 is in the 1 pg/mL range, with slight elevations during the menstrual cycle, modest elevations in certain cancers, and large elevations after surgery (34-38).IL-6 induces signaling through a cell surface heterodimeric receptor complex composed of a ligand binding subunit (IL-6 R) and a signal transducing subunit (gp130). IL-6 binds to IL-6 R, triggering IL-6 R association with gp130 and gp130 dimerization (39). gp130 is also a component of the receptors for CLC, CNTF, CT-1, IL-11, IL-27, LIF, and OSM (40). Soluble forms of IL-6 R are generated by both alternate splicing and proteolytic cleavage (3). In a mechanism known as trans-signaling, complexes of soluble IL-6 and IL-6 R elicit responses from gp130-expressing cells that lack cell surface IL-6 R (1, 3). Trans-signaling enables a wider range of cell types to respond to IL-6, as the expression of gp130 is ubiquitous, while that of IL-6 R is predominantly restricted to hepatocytes, monocytes, and resting lymphocytes (1-3). Soluble splice forms of gp130 block trans-signaling from IL-6/IL-6 R but not from other cytokines that use gp130 as a co-receptor (3, 41).IL-6, along with TNF-a and IL-1, drives the acute inflammatory response, is almost solely responsible for fever and the acute phase response in the liver, and is important in the transition from acute inflammation to either acquired immunity or chronic inflammatory disease (1-4). It contributes to chronic inflammation in conditions such as obesity, insulin resistance, inflammatory bowel disease, inflammatory arthritis, and sepsis when dysregulated, often involving IL-6 trans-signaling (1, 2). It plays an important role in differentiation of naïve T cells to Th17 inflammatory cells in the presence of TGF-b. IL-6 modulates bone resorption and is a major effector in inflammatory joint destruction in rheumatoid arthritis through promoting Th17 T cell activity (1). It contributes to atherosclerotic plaque development and destabilization (2). IL-6 can also have anti-inflammatory effects, however, such as in skeletal muscle where it is secreted in response to exercise (2). It promotes hematopoiesis by being a growth factor for hematopoietic stem cells, induces B cell maturation to plasma cells, and perpetuates multiple myeloma (1, 42). IL-6 also promotes, but probably does not initiate, other types of inflammation-associated carcinogenesis, such as colitis-associated cancer (1). The Quantikine HS Human IL-6 Immunoassay is a 5.5 hour solid-phase ELISA designed to measure human IL-6 in serum, plasma, and urine. It contains E. coli-expressed recombinant human IL-6 and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human IL-6 showed linear curves that were parallel to the standard curves obtained using the Quantikine HS kit standards. These results indicate that this kit can be used to determine relative mass values for naturally occurring human BAFF.alues for naturally occurring IL-6.
Storage instructions: Store the unopened kit at 2-8 °C. Do not use past kit expiration date.
PDF Link: http://www.rndsystems.com/pdf/hs600b.pdf
Sensitivity: Seventy-one assays were evaluated and the minimum detectable dose (MDD) of IL-6 ranged from 0.016-0.

Reviews (1)

4 - Excellent (Publishable / Ideal reagent)
Application: ELISA
Sample: human dendritic cells
Buffer: kit dilution buffer
Dilution: 1/100
See all reviews

1DegreeBio goes to great lengths to ensure the accuracy of the product information listed on the site, but we still encourage you to check with vendors to confirm product details before purchasing.

About R&D Systems

R&D Systems was founded in 1976 in Minneapolis, MN. It is a wholly owned subsidiary of TECHNE Corporation (a holding company with no employees). TECHNE has two operating subsidiaries: Research & Diagnostics Systems, Inc. (R&D Systems) and R&D Systems Europe Ltd. (R&D Europe). R&D Systems has two operating divisions: Biotechnology, which manufactures reagents primarily for the research market, and Hematology, which manufactures controls and calibrators for hematology analyzers. In July, 2005 R&D Systems purchased BiosPacific, which became a wholly owned subsidiary. BiosPacific is located in Emeryville, CA and consists of a sales force which provides products for development of Immunoassay kits. R&D Systems Europe in Abingdon, England distributes biotechnology products and is the European Representative for the Biotech Division. They received ISO 9001: 2000 certification in June, 2007. R&D Systems Europe has a sales subsidiary, R&D Systems GmBH, in Germany. R&D Systems established a wholly owned subsidiary in the People's Republic of China in May 2007. R&D Systems China Co. Ltd. officially opened its warehouse and distribution center in Shanghai, China on October 1, 2007. R&D China will provide products and marketing and technical support to their Chinese distributors. R&D Systems physical plant includes over 498,460 square feet of laboratory, manufacturing, and office space.